ELUT

Conviction 18HealthcareScan · Mon, Aug 10, 2026

ELUT$0.8243-3.02%

ResistanceSupportVol 14

Vol MA14 46.65K

May 11May 28Jun 16Jul 6Jul 23Aug 10

ELUTIA INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.elutia.com ↗

Price0.8243

Change-3.02%

Gap-3.02%

Rel volume0.00×

Avg volume93.85K

Avg $ vol87.26K

SMA 200.9065

SMA 500.9559

SMA 2000.9387

Price vs 50-13.76%

Price vs 200-12.18%

MA stackmixed

50/200 cross—

Supertrenddown · 0.9929

RSI (14)35

MACD hist-0.01

MACD crossbear · 8d

Stoch %K / %D8 / 22

ADX (14)18

+DI / −DI10 / 23

RSI divergence—

MACD divergence—

ATR %+7.17%

ADR %6.00%

52w high2.40

52w low0.5050

From 52w high-65.65%

Above 52w low+63.23%

New 52w highNo

SqueezeOn · 32d

Bollinger width17.57%

%B-0.02

Donchian pos7.53%

Donchian high1.00

Donchian low0.8100

AVWAP (52w high)0.9202

vs AVWAP high-10.42%

AVWAP (52w low)0.8872

vs AVWAP low-7.09%

OBV trendDown

Chaikin MF (20)-0.40

Today vs 20d0.00×

Avg vol (14d)46.65K

Avg vol (20d)93.85K

Avg $ vol (20d)87.26K

Market cap—

RS 3m (vs SPY)-20.60%

RS 6m (vs SPY)-23.93%

RS line new highNo

Trend template2/8

Technical rank15.6

1 week-4.91%

1 month-14.40%

3 months-18.39%

6 months-16.49%

1 year-58.37%

YTD+28.16%

P/E0.01

P/B0.02

P/S0.05

P/FCF-0.01

EPS0.8700

Div yield—

ROE236.96%

ROA96.69%

Debt/Eq1.16

Current2.05

EV/EBITDA0.08

Gross margin53.66%

Net margin434.23%

Rev growth-15.03%

EPS growth198.95%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-1.83M

Revenue3.11M

Net income-7.47M

Gross profit1.8M

Free cash flow-46.69M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out44.21M

Employees26

ListedThu, Oct 8, 2020

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction18 / 100

Pattern quality—

Tech rank15.6 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.05

Support0.8171

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ELUT

All disclosures →

No recent disclosed trades by Congress in ELUT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ELUT · 1 buy · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Mills C Randal PRESIDENT AND CEO · Class A Common Stock · 2026-06-21	Exercise	22.47K	—	2026-06-21	2026-06-22
Mills C Randal PRESIDENT AND CEO · Class A Common Stock · 2026-06-21	Tax	8.06K	$9K	2026-06-21	2026-06-22
Mills C Randal PRESIDENT AND CEO · Restricted Stock Units · 2026-06-21	Exercise	22.47K	—	2026-06-21	2026-06-22

SEC filings

EDGAR filings in ELUT · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.